Works matching DE "CONSOLIDATION chemotherapy"

Results: 154
    1
    2
    3
    4

    Multimodal assessment after total neoadjuvant therapy versus standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer accurately predicts complete responders.

    Published in:
    International Journal of Colorectal Disease, 2023, v. 38, n. 1, p. 1, doi. 10.1007/s00384-023-04526-2
    By:
    • Özoran, Emre;
    • Özata, İbrahim Halil;
    • Uymaz, Derya Salim;
    • Omarov, Nail;
    • Bozkurt, Emre;
    • Tüfekçi, Tutku;
    • Karahan, Salih Nafiz;
    • Gürbüz, Bülent;
    • Selçukbiricik, Fatih;
    • Bölükbaşı, Yasemin;
    • Taşkın, Orhun Çığ;
    • Gürses, Bengi;
    • Rencüzoğulları, Ahmet;
    • Buğra, Dursun;
    • Balık, Emre
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial.

    Published in:
    Leukemia (08876924), 2006, v. 20, n. 10, p. 1723, doi. 10.1038/sj.leu.2404356
    By:
    • Jehn, U.;
    • Suciu, S.;
    • Thomas, X.;
    • Lefrère, F.;
    • Muus, P.;
    • Berneman, Z.;
    • Marie, J-P.;
    • Adamo, F.;
    • Fillet, G.;
    • Nobile, F.;
    • Ricciuti, F.;
    • Leone, G.;
    • Rizzoli, V.;
    • Montanaro, M.;
    • Beeldens, F.;
    • Fazi, P.;
    • Mandelli, F.;
    • Willemze, R.;
    • de Witte, T.;
    • Amadori, S.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21

    The loss or absence of minimal residual disease of <0·1% at any time after two cycles of consolidation chemotherapy in CBFB–MYH11‐positive acute myeloid leukaemia indicates poor prognosis.

    Published in:
    British Journal of Haematology, 2021, v. 192, n. 2, p. 265, doi. 10.1111/bjh.16745
    By:
    • Duan, Wenbing;
    • Liu, Xiaohong;
    • Jia, Jinsong;
    • Wang, Jing;
    • Gong, Lizhong;
    • Jiang, Qian;
    • Zhao, Ting;
    • Wang, Yu;
    • Zhang, Xiaohui;
    • Xu, Lanping;
    • Zhao, Xiaosu;
    • Qin, Yazhen;
    • Shi, Hongxia;
    • Chang, Yingjun;
    • Huang, Xiaojun;
    • Jiang, Hao
    Publication type:
    Article
    22

    Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancer.

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2018, v. 14, n. 1, p. 91, doi. 10.1111/ajco.12749
    By:
    • Takhar, Harminder;
    • Singhal, Nimit;
    • Mislang, Anna;
    • Kumar, Raj;
    • Kim, Laurence;
    • Selva‐Nayagam, Sid;
    • Pittman, Ken;
    • Karapetis, Chris;
    • Borg, Martin;
    • Olver, Ian N.;
    • Brown, Michael P.
    Publication type:
    Article
    23

    An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non-small cell lung cancer.

    Published in:
    Asia Pacific Journal of Clinical Oncology, 2016, v. 12, n. 4, p. 380, doi. 10.1111/ajco.12513
    By:
    • Wang, Luhua;
    • Wu, Yi‐Long;
    • Lu, Shun;
    • Deng, Lei;
    • Ahn, Myung‐Ju;
    • Hsu, Feng‐Ming;
    • Iscoe, Neill;
    • Hossain, Anwar;
    • Puri, Tarun;
    • Zhang, Pinghai;
    • Orlando, Mauro
    Publication type:
    Article
    24
    25

    Safety and Pharmacokinetics of Quizartinib Combination Therapy With Standard Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results from Two Phase 1 Trials in Japan and China.

    Published in:
    Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 560, doi. 10.1002/cpdd.1353
    By:
    • Qi, Junyuan;
    • Choi, Ilseung;
    • Ota, Shuichi;
    • Ichikawa, Satoshi;
    • Fujishima, Naohito;
    • Iida, Hiroatsu;
    • Sugiura, Isamu;
    • Sugiura, Koichi;
    • Murata, Yasuharu;
    • Inoue, Hiroyuki;
    • Ohwada, Shoichi;
    • Wang, Jianxiang
    Publication type:
    Article
    26
    27
    28
    29
    30
    31

    Is RAPIDO too rapid for rectal cancer?

    Published in:
    ANZ Journal of Surgery, 2023, v. 93, n. 10, p. 2289, doi. 10.1111/ans.18481
    By:
    • Warrier, Satish K.;
    • Mohan, Helen;
    • Pham, Toan D.;
    • McCormick, Jacob;
    • Heriot, Alexander G.
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38

    Impact of different chemotherapy regimens on intestinal mucosal injury assessed with bedside ultrasound: a study in 213 AML patients.

    Published in:
    Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1272072
    By:
    • Benedetti, Edoardo;
    • Traverso, Ginevra;
    • Pucci, Giulia;
    • Morganti, Riccardo;
    • Bramanti, Emilia;
    • Lippolis, Piero;
    • Susini, Maria Chiara;
    • Mazzantini, Elisa;
    • Giubbolini, Rachele;
    • Mavilia, Fabrizio;
    • Capochiani, Enrico;
    • Neri, Emanuele;
    • Arena, Chiara;
    • Cerri, Francesca;
    • De Simone, Luigi;
    • Valentini, Katia;
    • Stella, Salvatore Massimo;
    • Ricchiuto, Vittorio;
    • Bruno, Benedetto;
    • Galimberti, Sara
    Publication type:
    Article
    39
    40
    41

    Correction to: Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant.

    Published in:
    Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0715-8
    By:
    • Wang, Jing-Zhi;
    • Chen, Yu-Hong;
    • Chen, Yao;
    • Wang, Feng-rong;
    • Sun, Yu-Qian;
    • Mo, Xiao-Dong;
    • Han, Wei;
    • Chen, Huan;
    • Xu, Lan-Ping;
    • Yan, Chen-Hua;
    • Wang, Yu;
    • Zhang, Xiao-hui;
    • Liu, Kai-Yan;
    • Huang, Xiao-Jun
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50

    The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC.

    Published in:
    Oncologist, 2024, v. 29, n. 7, p. 609, doi. 10.1093/oncolo/oyae107
    By:
    • Chang, Allison E B;
    • Piper-Vallillo, Andrew J;
    • Mak, Raymond H;
    • Lanuti, Michael;
    • Muzikansky, Alona;
    • Rotow, Julia;
    • Jänne, Pasi A;
    • Mino-Kenudson, Mari;
    • Swanson, Scott;
    • Wright, Cameron D;
    • Kozono, David;
    • Marcoux, Paul;
    • Piotrowska, Zofia;
    • Sequist, Lecia V;
    • Willers, Henning
    Publication type:
    Article